EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SI-BONE's Enterprise Value is $458.5 Mil.
SI-BONE's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $-25.2 Mil. Therefore, SI-BONE's EV-to-FCF for today is -18.18.
The historical rank and industry rank for SI-BONE's EV-to-FCF or its related term are showing as below:
SIBN'
s EV-to-FCF Range Over the Past 10 Years
Min: -55.17 Med: -16.6 Max: -4.72
Current: -18.18
During the past 8 years, the highest EV-to-FCF of SI-BONE was -4.72. The lowest was -55.17. And the median was -16.60.
SIBN's EV-to-FCF is ranked worse than 100% of 374
companies
in the Medical Devices & Instruments industry
Industry Median: 28.735
vs SIBN: -18.18
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2024-12-15), SI-BONE's stock price is $13.42.
SI-BONE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-0.920. Therefore, SI-BONE's PE Ratio (TTM) for today is At Loss.
SI-BONE EV-to-FCF Historical Data
The historical data trend for SI-BONE's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SI-BONE's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SI-BONE's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SI-BONE's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where SI-BONE's EV-to-FCF falls into.
SI-BONE's current Enterprise Value is $458.5 Mil.
SI-BONE's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SI-BONE (NAS:SIBN) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
SI-BONE's share price for today is $13.42.
SI-BONE's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.920.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
SI-BONE EV-to-FCF Related Terms
Thank you for viewing the detailed overview of SI-BONE's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SIBN has been successfully added to your 